Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous peripheral blood stem cell therapy for end-stage liver disease
ChiCTR-ONRC-10002070Phase 2Completed
- Sponsor
- Air Force Medical University
- Start
- Aug 2005
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of autologous peripheral blood stem cell in hepatic disease and Cirrhosis (2 arms), sponsored by Air Force Medical University. Primary endpoints: Death and Liver transplantation. Started Aug 2005; status: completed.
02
Drugs
autologous peripheral blood stem cell
03
Conditions
hepatic diseaseCirrhosis
Beyond the preview
Go deeper on ChiCTR-ONRC-10002070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONRC-10002070.